Dachaigh › Cairtean uaine › Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc.: sponsorachadh cairt uaine (PERM)
Chuir Allogene Therapeutics, Inc. 4 iarrtasan dearbhaidh obrach PERM a chaidh a dhearbhadh ann am bliadhnaichean ionmhais 2024–2026; dearbhte: 3. Tuarastal meadhanach tairgte $135,000; ùine mheadhanach bhon chur-a-steach chun dearbhadh: 471 làithean.
Tuarastalan H-1B aig Allogene Therapeutics, Inc. →
Tiotalan dreuchd
| Tiotal dreuchd | Iarrtasan PERM | Tuarastal meadhanach |
|---|---|---|
| Scientist, Process Development | 1 | $115,000 |
| Scientist | 1 | $135,000 |
| Senior Clinical Trial Manager | 1 | $189,000 |
| Scientist, Cell Engineering | 1 | — |
Làraich obrach
Gnìomhan
Co-dhùnaidhean as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Air a cho-dhùnadh | Inbhe | Làithean |
|---|---|---|---|---|---|---|
| Senior Clinical Trial Manager | $189,000–$210,000 | South San Francisco, CA | 13 Samh 2024 | 25 Màrt 2026 | Dearbhte | 497 |
| Scientist | $135,000–$155,000 | South San Francisco, CA | 24 Dàmh 2023 | 5 Gearr 2025 | Dearbhte, a’ dol seachad | 470 |
| Scientist, Process Development | $115,000–$135,000 | South San Francisco, CA | 23 Dàmh 2023 | 5 Gearr 2025 | Dearbhte, a’ dol seachad | 471 |
| Scientist, Cell Engineering | $115,000–$135,000 | South San Francisco, CA | 23 Dàmh 2023 | 19 Màrt 2024 | Air a tharraing air ais | — |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; bidh na staitistigean a’ cleachdadh iarrtasan làn-ùine teisteanasach. Is e teisteanas PERM aon cheum a dh’ionnsaigh caird-uaine; bidh USCIS a’ co-dhùnadh an ath-thagraidh. Chan e comhairle laghail a th’ ann. Stòr: Roinn Obrach nan SA, Dàta Foillseachaidh OFLC PERM, bliadhnaichean ionmhais 2024–2026 (co-dhùnadh as ùire 30 Ògmh 2026).